SiO2 Scales Manufacturing of Hybrid Vial Capacity for 400 Million Doses of COVID-19 Vaccine Achieved Ahead of Schedule

As COVID-19 vaccines move into late-stage testing, governments and drugmakers are scrambling to secure packaging